Cite

    Georgina Nakafero et al.. “What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?.” Rheumatology, vol. 60, 2021, pp. 5785–5794. http://access.bl.uk/ark:/81055/vdc_100148063125.0x000028